Korro Bio (KRRO) Change in Accured Expenses (2018 - 2026)

Korro Bio (KRRO) has 9 years of Change in Accured Expenses data on file, last reported at -$205000.0 in Q1 2026.

• Quarterly Change in Accured Expenses rose 91.84% year-over-year to -$205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 360.96% YoY) and the FY2025 annual result came in at $1.4 million, up 136.05% from the prior year.
• Change in Accured Expenses slipped to -$205000.0 in Q1 2026, from $1.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q2 2025 to a low of -$5.0 million in Q1 2024.
• A 5-year average of -$88941.2 and a median of $225000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 767.11% — and 2024, when it plunged 351.92%.
• Tracing KRRO's Change in Accured Expenses over 5 years: stood at $357000.0 in 2022, then slumped by 228.85% to -$460000.0 in 2023, then jumped by 273.04% to $796000.0 in 2024, then surged by 119.85% to $1.8 million in 2025, then plunged by 111.71% to -$205000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$205000.0 (Q1 2026), $1.8 million (Q4 2025), and $189000.0 (Q3 2025), per Business Quant data.